Patents by Inventor Saskia Braber

Saskia Braber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BETA-1,3'-GALACTOSYLLACTOSE FOR THE TREATMENT OF GUT BARRIER FUNCTION DISEASES
    Publication number: 20220218728
    Abstract: The invention relates to the use of beta1,3?-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barrier permeability, preferably infants and young children.
    Type: Application
    Filed: May 15, 2020
    Publication date: July 14, 2022
    Applicant: N.V. Nutricia
    Inventors: Saskia Braber, Belinda Potappel - van 't Land, Selma Paulien Wiertsema, Johan Garssen, Bernd Stahl, Marko Mank
  • NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND 3'GALACTOSYLLACTOSE
    Publication number: 20220110985
    Abstract: The invention pertains to a nutritional composition for infants or young children comprising 2?fucosyllactose, and 3?galactosyllactose, and preferably dietary butyric acid.
    Type: Application
    Filed: June 4, 2020
    Publication date: April 14, 2022
    Applicant: N.V. Nutricia
    Inventors: Belinda Potappel - van 't Land, Ingrid Brunhilde Renes, Selma Paulien Wiertsema, Gabriël Thomassen, Saskia Adriana Overbeek, Kaouther Ben Amor, Saskia Braber
  • NUTRITIONAL COMPOSITION COMPRISING 2'FUCOSYLLACTOSE AND DIETARY BUTYRATE
    Publication number: 20220079962
    Abstract: The invention pertains to a nutritional composition for infants or young children comprising 2?fucosyllactose, dietary butyrate and optionally 3?galactosyllactose.
    Type: Application
    Filed: June 4, 2020
    Publication date: March 17, 2022
    Applicant: N.V. Nutricia
    Inventors: Belinda Potappel - van 't Land, Ingrid Brunhilde Renes, Selma Paulien Wiertsema, Gabriël Thomassen, Saskia Adriana Overbeek, Kaouther Ben Amor, Saskia Braber
  • Treatment of conditions associated with mycotoxin exposure
    Patent number: 9782422
    Abstract: We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligosaccharide and/or fructooligosaccharide. The non-digestible oligosaccharide may comprise a short chain galacto-oligosaccharide (scGOS) and/or short chain fructooligosaccharide (scFOS). The trichothecene mycotoxin exposure associated condition may be associated with exposure to deoxynivalenol.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: October 10, 2017
    Assignee: N.V. Nutricia
    Inventors: Johan Garssen, Hermiena Christina Schoterman, Johanna Fink-Gremmels, Saskia Braber
  • TREATMENT OF CONDITIONS ASSOCIATED WITH MYCOTOXIN EXPOSURE
    Publication number: 20150164931
    Abstract: We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligosaccharide and/or fructooligosaccharide. The non-digestible oligosaccharide may comprise a short chain galacto-oligosaccharide (scGOS) and/or short chain fructooligosaccharide (scFOS). The trichothecene mycotoxin exposure associated condition may be associated with exposure to deoxynivalenol.
    Type: Application
    Filed: May 17, 2013
    Publication date: June 18, 2015
    Applicant: N.V. Nutricia
    Inventors: Johan Garssen, Hermiena Christina Schoterman, Johanna Fink-Gremmels, Saskia Braber